Study on the Protection of Celecoxib on Experimental Type 2 Diabetic Rat

陈健,贾汝汉,余堂宏,熊艳

DOI: https://doi.org/10.3969/j.issn.1008-0805.2004.09.003

2004-01-01

Abstract:Objective:To investigate the protection of celecoxib in experimental type 2 diabetic rat.Methods:Thirty-six rats were randomly divided into control groups and model groups,the rats of model group were given streptozotocin(STZ) after having the sucrose- and fat-enriched diets for 4 weeks in order to develop a rat model of type 2 diabetes,then rats were randomly divided into control groups ,diabets groups and treat groups.After 12 weeks the change of serum creatinine,urine creatinine,trace quantity of urine albumin,blood sucrose, were observed at the same time,the nuclear factor-kappa B(NF-κB) and CD68 in the nephridial tissue were detected, correlation analysis was done. Results:After 12 weeks,the blood sucrose、creatinine clearance rate (Ccr) 、trace quantity of urine albumin and nephros weight/body weight of diabets group are more than those of control group,those of treat group are lower than those of diabets group.The difference of insuline is not obvious between 3 groups.The express of NF-κB、CD68 in diabets group is more obvious than that of control group, the express of NF-κB、CD68 is lower after 12 weeks.Conclusion: Celecoxib can protect the nephros in the early stage of 2 diabetic,the mechanism is associated,at least in part,with down-regulating NF-κB activation and monocyte/macrophage recruitment in renal tissue.